目次

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Product
1.2.2. End User
1.3. Estimates and Forecast Timeline
1.4. Research Methodology
1.5. Information Procurement
1.5.1. Purchased Database
1.5.2. GVR’s Internal Database
1.5.3. Secondary Sources
1.5.4. Primary Research
1.6. Information Analysis
1.6.1. Data Analysis Models
1.7. Market Formulation & Data Visualization
1.8. Model Details
1.8.1. Commodity Flow Analysis
1.9. List of Secondary Sources
1.10. Objectives

Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot

Chapter 3. Dengue Vaccine Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.2. Market Restraint Analysis
3.3. Business Environment Analysis
3.3.1. Industry Analysis - Porter’s Five Forces Analysis
3.3.1.1. Supplier Power
3.3.1.2. Buyer Power
3.3.1.3. Substitution Threat
3.3.1.4. Threat of New Entrants
3.3.1.5. Competitive Rivalry
3.3.2. PESTLE Analysis
3.3.3. Pipeline Analysis
3.3.4. Patent Expiry Analysis
3.3.5. Pricing Analysis

Chapter 4. Dengue Vaccine Market: Product Business Analysis
4.1. Product Market Share, 2024 & 2033
4.2. Product Segment Dashboard
4.3. Market Size & Forecasts and Trend Analysis, by Product, 2021 to 2033 (USD Million)
4.4. Dengvaxia
4.4.1. Dengvaxia Market, 2021 - 2033 (USD Million)
4.5. Qdenga
4.5.1. Qdenga Market, 2021 - 2033 (USD Million)
4.6. Others
4.6.1. Others Market, 2021 - 2033 (USD Million)

Chapter 5. Dengue Vaccine Market: End User Business Analysis
5.1. End User Market Share, 2024 & 2033
5.2. End User Segment Dashboard
5.3. Market Size & Forecasts and Trend Analysis, by End User, 2021 to 2033 (USD Million)
5.4. Government & Public Health Agencies
5.4.1. Government & Public Health Agencies Market, 2021 - 2033 (USD Million)
5.5. Hospitals & Specialty Clinics
5.5.1. Hospitals & Specialty Clinics Market, 2021 - 2033 (USD Million)
5.6. Others
5.6.1. Others Market, 2021 - 2033 (USD Million)

Chapter 6. Dengue Vaccine Market: Regional Estimates & Trend Analysis
6.1. Regional Market Share Analysis, 2024 & 2033
6.2. Regional Market Dashboard
6.3. Market Size & Forecasts Trend Analysis, 2021 to 2033:
6.4. North America
6.4.1. North America Dengue Vaccine Market Estimates and Forecasts, By Country, 2021 - 2033 (USD Million)
6.4.2. U.S.
6.4.2.1. Key Country Dynamics
6.4.2.2. Target Disease Prevalence
6.4.2.3. Regulatory Framework
6.4.2.4. Reimbursement Framework
6.4.2.5. U.S. Dengue Vaccine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.4.3. Canada
6.4.3.1. Key Country Dynamics
6.4.3.2. Target Disease Prevalence
6.4.3.3. Regulatory Framework
6.4.3.4. Reimbursement Framework
6.4.3.5. U.S. Dengue Vaccine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.4.4. Mexico
6.4.4.1. Key Country Dynamics
6.4.4.2. Target Disease Prevalence
6.4.4.3. Regulatory Framework
6.4.4.4. Reimbursement Framework
6.4.4.5. Mexico Dengue Vaccine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.5. Europe
6.5.1. Europe Dengue Vaccine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.5.2. UK
6.5.2.1. Key Country Dynamics
6.5.2.2. Target Disease Prevalence
6.5.2.3. Regulatory Framework
6.5.2.4. Reimbursement Framework
6.5.2.5. Uk Dengue Vaccine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.5.3. Germany
6.5.3.1. Key Country Dynamics
6.5.3.2. Target Disease Prevalence
6.5.3.3. Regulatory Framework
6.5.3.4. Reimbursement Framework
6.5.3.5. Germany Dengue Vaccine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.5.4. France
6.5.4.1. Key Country Dynamics
6.5.4.2. Target Disease Prevalence
6.5.4.3. Regulatory Framework
6.5.4.4. Reimbursement Framework
6.5.4.5. France Dengue Vaccine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.5.5. Italy
6.5.5.1. Key Country Dynamics
6.5.5.2. Target Disease Prevalence
6.5.5.3. Regulatory Framework
6.5.5.4. Reimbursement Framework
6.5.5.5. Italy Dengue Vaccine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.5.6. Spain
6.5.6.1. Key Country Dynamics
6.5.6.2. Target Disease Prevalence
6.5.6.3. Regulatory Framework
6.5.6.4. Reimbursement Framework
6.5.6.5. Spain Dengue Vaccine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.5.7. Denmark
6.5.7.1. Key Country Dynamics
6.5.7.2. Target Disease Prevalence
6.5.7.3. Regulatory Framework
6.5.7.4. Reimbursement Framework
6.5.7.5. Denmark Dengue Vaccine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.5.8. Sweden
6.5.8.1. Key Country Dynamics
6.5.8.2. Target Disease Prevalence
6.5.8.3. Regulatory Framework
6.5.8.4. Reimbursement Framework
6.5.8.5. Sweden Dengue Vaccine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.5.9. Norway
6.5.9.1. Key Country Dynamics
6.5.9.2. Target Disease Prevalence
6.5.9.3. Regulatory Framework
6.5.9.4. Reimbursement Framework
6.5.9.5. Norway Dengue Vaccine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.6. Asia Pacific
6.6.1. Asia Pacific Dengue Vaccine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.6.2. Japan
6.6.2.1. Key Country Dynamics
6.6.2.2. Target Disease Prevalence
6.6.2.3. Regulatory Framework
6.6.2.4. Reimbursement Framework
6.6.2.5. Japan Dengue Vaccine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.6.3. China
6.6.3.1. Key Country Dynamics
6.6.3.2. Target Disease Prevalence
6.6.3.3. Regulatory Framework
6.6.3.4. Reimbursement Framework
6.6.3.5. China Dengue Vaccine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.6.4. India
6.6.4.1. Key Country Dynamics
6.6.4.2. Target Disease Prevalence
6.6.4.3. Regulatory Framework
6.6.4.4. Reimbursement Framework
6.6.4.5. India Dengue Vaccine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.6.5. Australia
6.6.5.1. Key Country Dynamics
6.6.5.2. Target Disease Prevalence
6.6.5.3. Regulatory Framework
6.6.5.4. Reimbursement Framework
6.6.5.5. Australia Dengue Vaccine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.6.6. South Korea
6.6.6.1. Key Country Dynamics
6.6.6.2. Target Disease Prevalence
6.6.6.3. Regulatory Framework
6.6.6.4. Reimbursement Framework
6.6.6.5. South Korea Dengue Vaccine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.6.7. Thailand
6.6.7.1. Key Country Dynamics
6.6.7.2. Target Disease Prevalence
6.6.7.3. Regulatory Framework
6.6.7.4. Reimbursement Framework
6.6.7.5. Thailand Dengue Vaccine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.7. Latin America
6.7.1. Latin America Dengue Vaccine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.7.2. Brazil
6.7.2.1. Key Country Dynamics
6.7.2.2. Target Disease Prevalence
6.7.2.3. Regulatory Framework
6.7.2.4. Reimbursement Framework
6.7.2.5. Japan Dengue Vaccine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.7.3. Argentina
6.7.3.1. Key Country Dynamics
6.7.3.2. Target Disease Prevalence
6.7.3.3. Regulatory Framework
6.7.3.4. Reimbursement Framework
6.7.3.5. China Dengue Vaccine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.8. Middle East and Africa
6.8.1. Middle East and Africa Dengue Vaccine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.8.2. South Africa
6.8.2.1. Key Country Dynamics
6.8.2.2. Target Disease Prevalence
6.8.2.3. Regulatory Framework
6.8.2.4. Reimbursement Framework
6.8.2.5. South Africa Dengue Vaccine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.8.3. Saudi Arabia
6.8.3.1. Key Country Dynamics
6.8.3.2. Target Disease Prevalence
6.8.3.3. Regulatory Framework
6.8.3.4. Reimbursement Framework
6.8.3.5. Saudi Arabia Dengue Vaccine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.8.4. UAE
6.8.4.1. Key Country Dynamics
6.8.4.2. Target Disease Prevalence
6.8.4.3. Regulatory Framework
6.8.4.4. Reimbursement Framework
6.8.4.5. UAE Dengue Vaccine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.8.5. Kuwait
6.8.5.1. Key Country Dynamics
6.8.5.2. Target Disease Prevalence
6.8.5.3. Regulatory Framework
6.8.5.4. Reimbursement Framework
6.8.5.5. Kuwait Dengue Vaccine Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Competitive Landscape
7.1. Participant Overview
7.2. Company Market Position Analysis
7.3. Company Categorization
7.4. Strategy Mapping
7.5. Company Profiles/Listing
7.5.1. Sanofi
7.5.1.1. Overview
7.5.1.2. Financial Performance
7.5.1.3. Product Benchmarking
7.5.1.4. Strategic Initiatives
7.5.2. Takeda Pharmaceutical Company Limited
7.5.2.1. Overview
7.5.2.2. Financial Performance
7.5.2.3. Product Benchmarking
7.5.2.4. Strategic Initiatives

List of Tables
Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 Global dengue vaccine market, by region, 2021 - 2033 (USD Million)
Table 4 Global dengue vaccine market, by product, 2021 - 2033 (USD Million)
Table 5 Global dengue vaccine market, by end user, 2021 - 2033 (USD Million)
Table 6 North America dengue vaccine market, by country, 2021 - 2033 (USD Million)
Table 7 North America dengue vaccine market, by product, 2021 - 2033 (USD Million)
Table 8 North America dengue vaccine market, by end user, 2021 - 2033 (USD Million)
Table 9 U.S. dengue vaccine market, by product, 2021 - 2033 (USD Million)
Table 10 U.S. dengue vaccine market, by end user, 2021 - 2033 (USD Million)
Table 11 Canada dengue vaccine market, by product, 2021 - 2033 (USD Million)
Table 12 Canada dengue vaccine market, by end user, 2021 - 2033 (USD Million)
Table 13 Mexico dengue vaccine market, by product, 2021 - 2033 (USD Million)
Table 14 Mexico dengue vaccine market, by end user, 2021 - 2033 (USD Million)
Table 15 Europe dengue vaccine market, by country, 2021 - 2033 (USD Million)
Table 16 Europe dengue vaccine market, by product, 2021 - 2033 (USD Million)
Table 17 Europe dengue vaccine market, by end user, 2021 - 2033 (USD Million)
Table 18 UK dengue vaccine market, by product, 2021 - 2033 (USD Million)
Table 19 UK dengue vaccine market, by end user, 2021 - 2033 (USD Million)
Table 20 Germany dengue vaccine market, by product, 2021 - 2033 (USD Million)
Table 21 Germany dengue vaccine market, by end user, 2021 - 2033 (USD Million)
Table 22 France dengue vaccine market, by product, 2021 - 2033 (USD Million)
Table 23 France dengue vaccine market, by end user, 2021 - 2033 (USD Million)
Table 24 Italy dengue vaccine market, by product, 2021 - 2033 (USD Million)
Table 25 Italy dengue vaccine market, by end user, 2021 - 2033 (USD Million)
Table 26 Spain dengue vaccine market, by product, 2021 - 2033 (USD Million)
Table 27 Spain dengue vaccine market, by end user, 2021 - 2033 (USD Million)
Table 28 Norway dengue vaccine market, by product, 2021 - 2033 (USD Million)
Table 29 Norway dengue vaccine market, by end user, 2021 - 2033 (USD Million)
Table 30 Denmark dengue vaccine market, by product, 2021 - 2033 (USD Million)
Table 31 Denmark dengue vaccine market, by end user, 2021 - 2033 (USD Million)
Table 32 Sweden dengue vaccine market, by product, 2021 - 2033 (USD Million)
Table 33 Sweden dengue vaccine market, by end user, 2021 - 2033 (USD Million)
Table 34 Asia Pacific dengue vaccine market, by country, 2021 - 2033 (USD Million)
Table 35 Asia Pacific dengue vaccine market, by product, 2021 - 2033 (USD Million)
Table 36 Asia Pacific dengue vaccine market, by end user, 2021 - 2033 (USD
Table 37 Million)
Table 38 Japan dengue vaccine market, by product, 2021 - 2033 (USD Million)
Table 39 Japan dengue vaccine market, by end user, 2021 - 2033 (USD Million)
Table 40 China dengue vaccine market, by product, 2021 - 2033 (USD Million)
Table 41 China dengue vaccine market, by end user, 2021 - 2033 (USD Million)
Table 42 India dengue vaccine market, by product, 2021 - 2033 (USD Million)
Table 43 India dengue vaccine market, by end user, 2021 - 2033 (USD Million)
Table 44 Australia dengue vaccine market, by product, 2021 - 2033 (USD Million)
Table 45 Australia dengue vaccine market, by end user, 2021 - 2033 (USD Million)
Table 46 South Korea dengue vaccine market, by product, 2021 - 2033 (USD Million)
Table 47 South Korea dengue vaccine market, by end user, 2021 - 2033 (USD Million)
Table 48 Thailand dengue vaccine market, by product, 2021 - 2033 (USD Million)
Table 49 Thailand dengue vaccine market, by end user, 2021 - 2033 (USD Million)
Table 50 Latin America dengue vaccine market, by country, 2021 - 2033 (USD Million)
Table 51 Latin America dengue vaccine market, by product, 2021 - 2033 (USD Million)
Table 52 Latin America dengue vaccine market, by end user, 2021 - 2033 (USD Million)
Table 53 Brazil dengue vaccine market, by product, 2021 - 2033 (USD Million)
Table 54 Brazil dengue vaccine market, by end user, 2021 - 2033 (USD Million)
Table 55 Argentina dengue vaccine market, by product, 2021 - 2033 (USD Million)
Table 56 Argentina dengue vaccine market, by end user, 2021 - 2033 (USD Million)
Table 57 Middle East & Africa Dengue vaccine market, by country, 2021 - 2033 (USD Million)
Table 58 Middle East & Africa dengue vaccine market, by product, 2021 - 2033 (USD Million)
Table 59 Middle East & Africa dengue vaccine market, by end user, 2021 - 2033 (USD Million)
Table 60 South Africa dengue vaccine market, by product, 2021 - 2033 (USD Million)
Table 61 South Africa dengue vaccine market, by end user, 2021 - 2033 (USD Million)
Table 62 Saudi Arabia dengue vaccine market, by product, 2021 - 2033 (USD Million)
Table 63 Saudi Arabia dengue vaccine market, by end user, 2021 - 2033 (USD Million)
Table 64 UAE dengue vaccine market, by product, 2021 - 2033 (USD Million)
Table 65 UAE dengue vaccine market, by end user, 2021 - 2033 (USD Million)
Table 66 Kuwait dengue vaccine market, by product, 2021 - 2033 (USD Million)
Table 67 Kuwait dengue vaccine market, by end user, 2021 - 2033 (USD Million)

List of Figures
Fig. 1 Dengue vaccine market segmentation
Fig. 2 Market research process
Fig. 3 Data triangulation techniques
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 Market formulation & validation
Fig. 8 Market snapshot
Fig. 9 Therapeutic approach and product outlook (USD Million)
Fig. 10 Competitive landscape
Fig. 11 Dengue vaccine market dynamics
Fig. 12 Dengue vaccine market: Porter’s five forces analysis
Fig. 13 Dengue vaccine market: PESTLE analysis
Fig. 14 Product market, 2021 - 2033 (USD Million)
Fig. 15 Dengvaxia market, 2021 - 2033 (USD Million)
Fig. 16 Qdenga market, 2021 - 2033 (USD Million)
Fig. 17 Others market, 2021 - 2033 (USD Million)
Fig. 18 End User market, 2021 - 2033 (USD Million)
Fig. 19 Government & Public Health Agencies market, 2021 - 2033 (USD Million)
Fig. 20 Hospitals & Specialty Clinics market, 2021 - 2033 (USD Million)
Fig. 21 Others market, 2021 - 2033 (USD Million)
Fig. 22 Dengue vaccine market revenue, by region
Fig. 23 Regional marketplace: Key takeaways
Fig. 24 North America dengue vaccine market, 2021 - 2033 (USD Million)
Fig. 25 U.S. country dynamics
Fig. 26 U.S. dengue vaccine market, 2021 - 2033 (USD Million)
Fig. 27 Canada country dynamics
Fig. 28 Canada dengue vaccine market, 2021 - 2033 (USD Million)
Fig. 29 Mexico country dynamics
Fig. 30 Mexico dengue vaccine market, 2021 - 2033 (USD Million)
Fig. 31 Europe dengue vaccine market, 2021 - 2033 (USD Million)
Fig. 32 UK country dynamics
Fig. 33 UK dengue vaccine market, 2021 - 2033 (USD Million)
Fig. 34 Germany country dynamics
Fig. 35 Germany dengue vaccine market, 2021 - 2033 (USD Million)
Fig. 36 France country dynamics
Fig. 37 France dengue vaccine market, 2021 - 2033 (USD Million)
Fig. 38 Italy country dynamics
Fig. 39 Italy dengue vaccine market, 2021 - 2033 (USD Million)
Fig. 40 Spain country dynamics
Fig. 41 Spain dengue vaccine market, 2021 - 2033 (USD Million)
Fig. 42 Norway country dynamics
Fig. 43 Norway dengue vaccine market, 2021 - 2033 (USD Million)
Fig. 44 Sweden country dynamics
Fig. 45 Sweden dengue vaccine market, 2021 - 2033 (USD Million)
Fig. 46 Denmark country dynamics
Fig. 47 Denmark dengue vaccine market, 2021 - 2033 (USD Million)
Fig. 48 Asia Pacific dengue vaccine market, 2021 - 2033 (USD Million)
Fig. 49 Japan country dynamics
Fig. 50 Japan dengue vaccine market, 2021 - 2033 (USD Million)
Fig. 51 China country dynamics
Fig. 52 China dengue vaccine market, 2021 - 2033 (USD Million)
Fig. 53 India country dynamics
Fig. 54 India dengue vaccine market, 2021 - 2033 (USD Million)
Fig. 55 Australia country dynamics
Fig. 56 Australia dengue vaccine market, 2021 - 2033 (USD Million)
Fig. 57 South Korea country dynamics
Fig. 58 South Korea dengue vaccine market, 2021 - 2033 (USD Million)
Fig. 59 Thailand country dynamics
Fig. 60 Thailand dengue vaccine market, 2021 - 2033 (USD Million)
Fig. 61 Latin America dengue vaccine market, 2021 - 2033 (USD Million)
Fig. 62 Brazil country dynamics
Fig. 63 Brazil dengue vaccine market, 2021 - 2033 (USD Million)
Fig. 64 Argentina country dynamics
Fig. 65 Argentina dengue vaccine market, 2021 - 2033 (USD Million)
Fig. 66 MEA dengue vaccine market, 2021 - 2033 (USD Million)
Fig. 67 South Africa country dynamics
Fig. 68 South Africa dengue vaccine market, 2021 - 2033 (USD Million)
Fig. 69 Saudi Arabia country dynamics
Fig. 70 Saudi Arabia dengue vaccine market, 2021 - 2033 (USD Million)
Fig. 71 UAE country dynamics
Fig. 72 UAE dengue vaccine market, 2021 - 2033 (USD Million)
Fig. 73 Kuwait country dynamics
Fig. 74 Kuwait dengue vaccine market, 2021 - 2033 (USD Million)
Fig. 75 Company categorization
Fig. 76 Company market position analysis
Fig. 77 Strategic framework